Code | 4094A | ||||||||||
MA number | 27/0040/13-S | ||||||||||
Product Form: | tbl plg 84x8 mg (blis.PVC/PCTFE/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 06.02.2013 |
Pediatric posology: | Yes |
SPC: | SPC_ROPINSTAD retard_08.2023.pdf |
PIL: | PIL_ROPINSTAD retard_08.2023.pdf |
Safety feature | Yes |
Data update: | 21.08.2018 |